Co-Diagnostics (CODX) Tops Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts CODX Hot Sheet
Join SI Premium – FREE
Co-Diagnostics (NASDAQ: CODX) reported Q2 EPS of ($0.25), $0.09 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $2.66 million versus the consensus estimate of $375 thousand.
For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KeyBanc Downgrades Primoris Services Corporation (PRIM) to Sector Weight
- Wolfe Research Downgrades Five Below (FIVE) to Peerperform
- Jefferies Reinstates Talen Energy (TLN) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
